GlassScriptPhysician profile
Roger Owens
NPI 1992774079
$1,611.42
in general payments reported to CMS, 2019-2025
25 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $150 · 2021: $63.15 · 2022: $137 · 2023: $72.78 · 2024: $298 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528 · Entertainment: $13.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.73 |
| Entertainment | $13.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $382.61 | 2019-2025 | Airsupra |
| Amgen INC. | $183.23 | 2019-2022 | |
| Abbott Laboratories | $140.90 | 2021-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.56 | 2019-2025 | Jardiance |
| Pfizer INC. | $126.38 | 2019-2024 | |
| Novo Nordisk INC | $117.56 | 2019-2025 | Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $63.03 | 2019-2021 | |
| Abbvie INC. | $60.58 | 2023-2024 | |
| Edwards Lifesciences Corporation | $58.16 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $47.51 | 2024 | Intellis Adaptivestim |
| Astellas Pharma US INC | $38.19 | 2019 | |
| Philips North America LLC | $28.55 | 2024 | (Ck7) Extended Holter |
| Bayer Healthcare Pharmaceuticals INC. | $24.79 | 2023 | |
| Janssen Pharmaceuticals, INC | $23.53 | 2024 | Spravato |
| Opko Pharmaceuticals, LLC | $20.75 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $19.61 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $19.22 | 2019 | |
| Globus Medical, INC. | $17.81 | 2025 | Senza |
| Azurity Pharmaceuticals, INC. | $16.88 | 2023 | Horizant |
| Exact Sciences Corporation | $16.84 | 2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $16.76 | 2020 | |
| Covis Pharma Gmbh | $15.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2025 | Xifaxan |
| Linus Health, INC. | $13.90 | 2022 | |
| Optos, INC. | $13.15 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.